June 30, 2015
Recommended Topic Related To:

Bicnu

"The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach./"...

BiCNU




Overdosage
Contraindications

OVERDOSE

No proven antidotes have been established for BiCNU (carmustine) overdosage.

CONTRAINDICATIONS

BiCNU (carmustine) should not be given to individuals who have demonstrated a previous hypersensitivity to it.

Last reviewed on RxList: 5/5/2011
This monograph has been modified to include the generic and brand name in many instances.

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.